Global Access to Duchenne Clinical Trials

Our Clinical Trials Hub makes it easier to find, explore, and compare Duchenne clinical trials. With AI-assisted updates and multilingual access, reliable clinical trial information is always within reach.

10 LANGUAGES

Worldwide Access

AI-POWERED

Always Updated

SMART INSIGHTS

Research Statistics

With a mission to cure Duchenne muscular dystrophy

Many people in the world do not know what Duchenne muscular dystrophy is. Because only one in every 5,000 boys gets this disease. However, families and their surroundings whose children struggle with this disease have to live with the stress of this disease every day. We call them DMD Warriors.

DMDWarrior.com was established to raise awareness of this disease worldwide, facilitate access to treatments, and ensure that treatment costs are affordable. Together, we will cure Duchenne muscular dystrophy!

DMD Warriors can overcome any challenge.

What is our purpose?

One in every 5,000 children in the world is born with DMD, and many families only realize their child has the disease when they are 3-4 years old. FDA-approved treatments for DMD are too expensive for families to afford. Our goal is to reduce treatment costs and have the costs covered by the government.

Home

Ease of Access to Treatments

In many countries, DMD treatments are not available, and families incur huge costs for travel abroad.

Home

Reducing Treatment Costs

Treatments for DMD are very expensive, and it is nearly impossible for families to cover these costs themselves.

Home

Raising Awareness on Social Media

We do not want any child to die. If you also want to find a solution to this situation, follow us on social media.

Duchenne News & Articles

FDA Allows Expanded Enrollment in Signature Biologics’ DMD Cell Therapy Study

Signature Biologics has announced that the U.S. Food and Drug Administration (FDA) has allowed expanded enrollment in a clinical study evaluating the company’s investigational...

Exon 45 Skipping in DMD: Deletions and Mutations That May Be Eligible

As of recent years, exon skipping has emerged as a promising therapeutic strategy for certain types of mutations in the dystrophin gene. Exon 45...

Mutations and Deletions Amenable to Exon 44 Skipping Therapies for Duchenne Muscular Dystrophy

Deletions amenable to exon 44 skipping are specific genetic changes in the DMD gene for which skipping exon 44 may restore the reading frame...

Do Social Media Hashtag Campaigns Really Help DMD Associations Improve Access to Approved Treatments for DMD Families?

Every year, dozens of Duchenne muscular dystrophy (DMD) associations organize social media campaigns encouraging families and supporters to share hashtags on platforms such as...

IPS HEART Aims to Restore Full-Length Dystrophin with Two Regenerative Cell Therapies for Duchenne Muscular Dystrophy

IPS HEART has announced another important regulatory milestone after receiving FDA Rare Pediatric Disease Designation for ISX9-CPC, its investigational cardiac muscle therapy for Duchenne...